Post-COVID-19 Syndrome
Conditions
Keywords
rehabilitation, maintenance program
Brief summary
Infection with SARS-CoV-2 virus leads to persistent symptoms for more than 12 weeks in 15% of cases ("post-COVID syndrome"). Symptoms like fatigue, dyspnoea, limitations in physical performance and activities, head ache, anxiety symptoms, and depression are heterogenous which limit physical health and participation in daily life activities. In the last years, multidisciplinary rehabilitation programs showed benefits in quality of life and symptom intensity in patients with post-COVID. Therefore, rehabilitation programs are recommended for individuals with Post-COVID by official sites like the German Society of Pulmonology and the European Respiratory Society. Own first data (published at the ERS conference 2023) revealed that one the one hand, inpatient rehabilitation is effective, however, on the other hand, it is challenging to maintain these effects after completing the program. Therefore, the aim of this study is to sustain these benefits by using a digital maintenance program following the rehabilitation program compared to usual care.
Interventions
PROCEDURERehabilitation combined to a digital maintenance program
Individuals in this group undergo a 3-week inpatient rehabilitation program followed by a 12-week maintenance program (2 sessions per week à 90 minutes, digital and live). The multimodal programs consist of physiotherapy, training therapy, medical support, cognitive training, education and psychological support.
PROCEDURERehabilitation without maintenance program
Individuals in this group undergo a 3-week inpatient rehabilitation program followed by a 12-week usual care period.
Sponsors
Schön Klinik Berchtesgadener Land
Bavarian State Ministry of Health and Care (Funding)
Deutsche Rentenversicherung (German pension insurance)
Betriebskrankenkassen Landesverband Bayern (Bavarian health insurance) (Design)
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Post-COVID-syndrome (Definition WHO) * Entered the rehabilitation process at the Schoen Klinik Berchtesgadener Land
Exclusion criteria
* No internet access
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change from baseline quality of life assessed by Short-Form 12 questionnaire at week 4 and week 19 | Baseline, week 4, week 19 | The scale of the physical and mental Health component summary score ranges from minimum 0 to maximum 100 points with higher scores indicating better quality of life |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change from baseline post-COVID-related symptoms at week 4 and week 19 | Baseline, week 4, week 19 | The number of COVID-symptoms will recorded as well as their intensity will be rated on a scale from 0 \[not relevant\] until 10 \[very severe symptom\]. |
| Change from baseline lung function at week 4 and week 19 | Baseline, week 4, week 19 | following Parameters will be collected:Pimax |
| Change from baseline fatigue symptoms at week 4 and week 19 | Baseline, week 4, week 19 | Fatigue Assessment Scale will be used |
| Change from baseline exercise capacity at week 4 and week 19 | Baseline, week 4, week 19 | 1-minute sit to stand test will be performed (maximum repetitions of squats in one minute) |
| Change from baseline physical activity at week 4 and week 19 | Baseline, week 4, week 19 | Activity will be measure in steps per day using a wearable from Polar |
| Change from baseline quality of life at week 4 and week 19 | Baseline, week 4, week 19 | EQ-5D-5L questionnaire will be used. |
| Change from the use of health care service at week 4 and week 19 | Baseline, week 4, week 19 | Frequency of therapeutical, medical and psychological sessions will be documented. |
| Change from the use of medications at week 4 and week 19 | Baseline, week 4, week 19 | Amount and kind of medication will be documented. |
| Change from rate of sickness at week 4 and week 19 | Baseline, week 4, week 19 | Days of sickness will be documented. |
| Change from workability at week 4 and week 19 | Baseline, week 4, week 19 | Work ability index will be used |
| Change from ICF functionality at week 4 and week 19 | Baseline, week 4, week 19 | Indicators of rehabilitation status questionnaire (IRES-3) will be used. |
| Change from sleep quality at week 4 and week 19 | Baseline, week 4, week 19 | Sleep quality will be assessed by using the Pittsburgh Sleep Quality Index (total score ranges from 0 to 21 with higher scores indicating higher impairment) |
| Change from depression symptoms at week 4 and week 19 | Baseline, week 4, week 19 | Patient Health Questionnaire 9 will be used. The total score ranges from 0 to 27 points with higher scores indicating worse Depression symptoms |
| Change from anxiety symptoms at week 4 and week 19 | Baseline, week 4, week 19 | Generalized Anxiety Disorder Scale 7 will be used. The total score ranges from 0 to 21 points with higher scores indicating more anxiety symptoms |
| Change from resilience at week 4 and week 19 | Baseline, week 4, week 19 | Resilience scale RS-13 will be used. |
| Change from cognition at week 4 and week 19 | Baseline, week 4, week 19 | Cognition will be measured via the software RehaCom (by Hasomed GmbH). |
| Change from cognitive impairment at week 4 and week 19 | Baseline, week 4, week 19 | Cognitive impairment will be measured by Montreal Cognitive Assessment (MoCA) |
Countries
Germany
Contacts
PRINCIPAL_INVESTIGATORAndreas R Koczulla, PROF
Schön Klinik Berchtesgadener Land
Outcome results
None listed